Literature DB >> 24287710

Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex.

Francesca Sampogna1, Dennis Linder, Stefano Piaserico, Gianfranco Altomare, Marco Bortune, Piergiacomo Calzavara-Pinton, Camilla Dalle Vedove, Giampiero Girolomoni, Andrea Peserico, Raffaella Sala, Damiano Abeni.   

Abstract

The aim of this study was to assess quality of life in patients with scalp dermatitis using the Italian version of the Scalpdex, and to validate the instrument in Italian. The survey was conducted in outpatients with psoriasis, seborrhoeic dermatitis, alopecia, or follicular lichen. Data were completed on 194 patients, 78% of whom had psoriasis. Scalpdex scores were always higher in women than in men, and in younger people compared to elderly people. The most frequent items were: being ashamed, embarrassed, bleeding scalp, feeling self-conscious, bothered that the condition is incurable, having the choice of colour of clothes affected, having a negative effect on daily life. The Italian Scalpdex showed good internal consistency, test-retest reliability, convergent validity, and responsiveness. In conclusion, the Italian version of the Scalpdex is a useful instrument to measure quality of life in patients with a scalp condition.

Entities:  

Mesh:

Year:  2014        PMID: 24287710     DOI: 10.2340/00015555-1731

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  9 in total

1.  Prevalence of psoriasis phenotypes among men and women in the USA.

Authors:  J F Merola; T Li; W-Q Li; E Cho; A A Qureshi
Journal:  Clin Exp Dermatol       Date:  2016-02-18       Impact factor: 3.470

Review 2.  Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems.

Authors:  Vijay Kodumudi; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

Review 3.  Underdiagnosed and undertreated psoriasis: Nuances of treating psoriasis affecting the scalp, face, intertriginous areas, genitals, hands, feet, and nails.

Authors:  Joseph F Merola; Abrar Qureshi; M Elaine Husni
Journal:  Dermatol Ther       Date:  2018-03-06       Impact factor: 2.851

4.  Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis.

Authors:  Ishrat Jahan; Md Rabiul Islam; Md Reazul Islam; Rubaiya Ali; S M Matiur Rahman; Zabun Nahar; Abul Hasnat; Md Saiful Islam
Journal:  Heliyon       Date:  2021-03-28

5.  Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea.

Authors:  Sang Wook Son; Dae Young Yu; Youngdoe Kim; Hyo Hyun Ahn; Yong Hyun Jang; Joo Young Roh; Young Bok Lee; Ji Yeoun Lee; Myung Hwa Kim; YoungJa Lee; Gyeong-Hun Park; Hyun-Sun Yoon; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

Review 6.  The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Odeh Alsmeirat; Som Lakhani; Musab Egaimi; Osama Idris; Mohamed Elkhalifa
Journal:  Cureus       Date:  2022-08-02

7.  Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.

Authors:  Leon Kircik; Joseph Fowler; Jonathan Weiss; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30

8.  Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.

Authors:  Alan Menter; Jennifer C Cather; Michael Jarratt; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30

9.  Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.

Authors:  Boni E Elewski; Andrew Blauvelt; Gaia Gallo; Eric Wolf; Missy McKean-Matthews; Russel Burge; Joseph F Merola; Alice B Gottlieb; Lyn C Guenther
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.